349,109 Shares in Evolent Health, Inc. (NYSE:EVH) Bought by Brighton Jones LLC

Brighton Jones LLC purchased a new stake in shares of Evolent Health, Inc. (NYSE:EVH) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 349,109 shares of the technology company’s stock, valued at approximately $3,927,000.

Several other institutional investors have also recently bought and sold shares of EVH. Covestor Ltd grew its position in Evolent Health by 138.1% in the 3rd quarter. Covestor Ltd now owns 1,424 shares of the technology company’s stock worth $40,000 after purchasing an additional 826 shares in the last quarter. GAMMA Investing LLC raised its position in Evolent Health by 5,365.5% in the third quarter. GAMMA Investing LLC now owns 1,585 shares of the technology company’s stock worth $45,000 after acquiring an additional 1,556 shares during the period. Quarry LP purchased a new position in Evolent Health in the second quarter valued at about $32,000. Canada Pension Plan Investment Board bought a new position in shares of Evolent Health during the 2nd quarter valued at approximately $61,000. Finally, Point72 Asia Singapore Pte. Ltd. increased its stake in shares of Evolent Health by 2,471.9% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,507 shares of the technology company’s stock worth $184,000 after purchasing an additional 6,254 shares during the last quarter.

Analyst Upgrades and Downgrades

EVH has been the topic of several research analyst reports. UBS Group dropped their price objective on Evolent Health from $27.00 to $14.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. Canaccord Genuity Group cut their price target on Evolent Health from $23.00 to $16.00 and set a “buy” rating for the company in a research note on Thursday. Needham & Company LLC started coverage on Evolent Health in a research note on Friday, January 10th. They set a “buy” rating and a $15.00 price objective on the stock. Stephens cut their price objective on Evolent Health from $16.00 to $12.00 and set an “equal weight” rating for the company in a report on Tuesday. Finally, Truist Financial lowered their target price on shares of Evolent Health from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Wednesday. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $19.31.

Evolent Health Price Performance

Shares of NYSE EVH opened at $10.16 on Friday. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a 50-day moving average of $11.50 and a 200 day moving average of $20.44. Evolent Health, Inc. has a 1 year low of $9.74 and a 1 year high of $35.00.

Evolent Health (NYSE:EVH) last announced its quarterly earnings data on Thursday, November 7th. The technology company reported ($0.08) EPS for the quarter, missing the consensus estimate of $0.30 by ($0.38). Evolent Health had a negative net margin of 2.93% and a positive return on equity of 6.30%. The firm had revenue of $621.40 million for the quarter, compared to analysts’ expectations of $625.58 million. During the same period last year, the company posted $0.19 earnings per share. Research analysts anticipate that Evolent Health, Inc. will post 0.26 earnings per share for the current fiscal year.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.